| News

Project uptown Basel taking shape

11.06.2019

A competence center for Industry 4.0 is being created on the former site of ABB. Private investors have contributed around half a million Swiss francs to the project. The foundation stone has now been officially laid.

Model of the Competence Center for Industry 4.0 (img. Fankhauser Arealentwicklungen)

The Schorenareal extends over an area of 70,000m2 and lies between the motorway and railway line, just a few hundred meters from Münchenstein station. For decades, it was home to manufacturing by ABB’s predecessor BBC. In 2016, the canton sold the site to Basel lawyer and investor Thomas Staehelin, President of the Chamber of Commerce of the two Basel cantons at the time. With uptown Basel AG, it is establishing a competence center for Industry 4.0. Construction began in March, with the foundation stone for phase one officially laid last Friday. The first building will offer lettable space of 25,000m2 over five floors, of which 70 percent has already leased, as site developer Hans-Jörg Fankhauser revealed in an article by the Basler Zeitung newspaper.

Around 500 million francs is being invested in the development by uptown Basel AG, which is expected to create approximately 2,000 jobs. With Axians and Bouygues, two major European technology companies are confirmed as moving to uptown. Cumulatively, they intend to offer 400 jobs at this site.

The economic director of Basel-Land Thomas Weber speaks of a renaissance for industry in the canton. “A quantum leap has been achieved with Staehelin’s project” he says in the newspaper article. “The historic potential of the site has been perfectly transformed for the future.”

The first building will be completed at the end of 2021. A further 10,000m2 of lettable space will follow down the line.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Botanikind settles in Basel
Basel Area Business & Innovation, Innovation, Invest

Botanikind settles in Basel

The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for...

Read More
Kinarus secures capital commitment of 57 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Kinarus secures capital commitment of 57 million Swiss francs

The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group...

Read More
Biotech startups from the Basel Area confirm leading position
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Biotech startups from the Basel Area confirm leading position

As part of the Top 100 Swiss Startup Awards 2021, the most promising startups in Switzerland are honored. These also...

Read More
T3 Pharma wins Swiss Economic Award
Basel Area Business & Innovation, Innovation, Invest

T3 Pharma wins Swiss Economic Award

T3 Pharma has won the Swiss Economic Award 2021. Switzerland’s most prestigious young entrepreneur prize is awarded by the Swiss...

Read More
Worg selects Basel Area for European headquarters
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Worg selects Basel Area for European headquarters

Worg Pharmaceuticals has opted to establish its European headquarters at the site Allschwil of the Switzerland Innovation Park Basel Area....

Read More
ten23 health settles in Basel
Basel Area Business & Innovation, Innovation, Invest

ten23 health settles in Basel

The life sciences cluster Rosental Mitte located in Basel is home to a new, globally active company called ten23 health....

Read More
Lumineo installs translucent concrete wall for Vinci
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Lumineo installs translucent concrete wall for Vinci

The global construction and energy group Vinci engaged the jurassic Lumineo Group to design a wall made from translucent concrete...

Read More
Roivant invests 200 million dollars in Immunovant
Basel Area Business & Innovation, Innovation, Invest

Roivant invests 200 million dollars in Immunovant

The Basel-based Roivant Group has invested a total of 200 million dollars in the US biopharmaceutical company Immunovant. This investment...

Read More
Lyfegen collaborating with Johnson & Johnson
Basel Area Business & Innovation, Innovation, Invest

Lyfegen collaborating with Johnson & Johnson

The Basel-based startup Lyfegen has developed a platform for value-based healthcare. This should provide improved outcomes for patients and result...

Read More
Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.